A Patent Review on SARS Coronavirus Main Protease (3CL pro ) Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Patent Review on SARS Coronavirus Main Protease (3CL pro ) Inhibitors

Published:2021-10-28 Issue:1 Volume:17 Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Chia C. S. Brian¹^ORCID,Xu Weijun¹,Shuyi Ng Pearly¹

Affiliation:

1. Experimental Drug Development Centre 10 Biopolis Road 138670 Chromos #08-01 Singapore

Funder

Agency for Science, Technology and Research

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202100576

Reference72 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

3. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

4. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

5. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking the Chain: Protease Inhibitors as Game Changers in Respiratory Viruses Management;International Journal of Molecular Sciences;2024-07-25

2. Unlocking Therapeutic Potential: Identifying Small Molecule Inhibitors for Sars-Cov-2 Variants' Main Protease (MPRO) Through Molecular Docking Analysis;Sains Malaysiana;2024-05-31

3. A study of the protease inhibitory activity component of SARS-CoV-2 3CL in Bletilla striata;Frontiers in Natural Products;2024-03-28

4. Personalized Drug Therapy: Innovative Concept Guided With Proteoformics;Molecular & Cellular Proteomics;2024-03

5. Recent Discovery of Triazine Derivatives as Protease Inhibitors for the Treatment of Coronavirus-19 (COVID-19);Current Organic Synthesis;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3